The prevalence, predictors and outcomes of guideline‐directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry
Authors:
- Zhen GeZGZhen Ge
- Usman BaberUBUsman Baber
- Bimmer E. ClaessenBCBimmer E. Claessen
- Serdar FarhanSFSerdar Farhan
- Jaya ChandrasekharJCJaya Chandrasekhar
- Shawn X. LiSLShawn X. Li
- Samantha SartoriSSSamantha Sartori
- Annapoorna S. KiniAKAnnapoorna S. Kini
- Sunil V. RaoSRSunil V. Rao
- Timothy D. HenryTHTimothy D. Henry
- Birgit VogelBVBirgit Vogel
- 23 October 2018
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 93 (3) , E112-E119
Abstract
Objectives: To investigate the prevalence, predictors and associations between guideline‐directed medical therapy (GDMT) and clinical outcomes in acute myocardial infarction (AMI) patients undergoing percutaneous coronary intervention (PCI) from eight academic centers in the United States.Background: Evidence for GDMT in patients with AMI comes from randomized controlled trials. The use of GDMT in clinical practice is unknown in this setting.Methods: PROMETHEUS is a multicenter observational registry comprising 19,914 patients with acute coronary syndrome (ACS) undergoing PCI. Patients with AMI were divided into two groups based on the prescription of GDMT or not (non‐GDMT) at discharge. GDMT was defined according to American College of Cardiology/American Heart Association (ACC/AHA) class I recommendations, specifically, dual antiplatelet therapy, statin and beta‐blocker for all AMI patients, and additional ACEI/ARB in patients with left ventricular ejection fraction (LVEF) less than 40%, hypertension, diabetes mellitus (DM) or chronic kidney disease (CKD). The primary endpoint was major adverse cardiovascular events (MACE) defined as a composite of all‐cause death, MI, stroke or unplanned target vessel revascularization (TVR) at 1 year.Results: Out of 4,834 patients with AMI, 3,356 (69.4%) patients were discharged on GDMT. Patients receiving GDMT were more often younger and male. Compared with non‐GDMT patients, GDMT patients had a significantly lower frequency of comorbidities. Predictors of greater GDMT prescription at discharge were ST‐segment elevation myocardial infarction (STEMI), and increased body mass index (BMI), whereas hypertension, prior PCI, anemia and CKD were associated with less GDMT prescription. At 1 year, the use of GDMT was associated with a significantly lower incidence of MACE (13.7% vs. 22.5%; adjusted HR 0.68; 95%CI 0.58–0.80; P < 0.001), death (3.7% vs. 9.4%; adjusted HR 0.61; 95%CI 0.46–0.80; P < 0.001), and unplanned TVR (8.4% vs. 11.3%; adjusted HR 0.76; 95%CI 0.61–0.96; P = 0.020). However, there were no significant differences in the incidence of MI (4.3% vs. 7.0%; adjusted HR 0.75; 95%CI 0.56–1.01; P = 0.056), stroke (1.5% vs. 2.0%; adjusted HR 0.79; 95%CI 0.47–1.34; P = 0.384) between the two groups.Conclusion: In a contemporary practice setting in the United States, GDMT was utilized in just over two‐thirds of AMI patients undergoing PCI. Predictors of GDMT prescription at discharge included STEMI, BMI and absence of hypertension, CKD, anemia or prior PCI. Use of GDMT was associated with significantly lower risk of 1‐year MACE and mortality.Keywords
Funding Information
- Daiichi Sankyo Company, Limited
- Eli Lilly and Company
This publication has 24 references indexed in Scilit:
- 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial InfarctionCirculation, 2011
- Contemporary Trends in Evidence-based Treatment for Acute Myocardial InfarctionThe American Journal of Medicine, 2010
- 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)Circulation, 2009
- Declining Severity of Myocardial Infarction From 1987 to 2002Circulation, 2009
- One-year health status outcomes of unstable angina versus myocardial infarction: a prospective, observational cohort study of ACS survivorsBMC Cardiovascular Disorders, 2007
- Increasing Use of Single and Combination Medical Therapy in Patients Hospitalized for Acute Myocardial Infarction in the 21st CenturyA Multinational PerspectiveArchives of internal medicine (1960), 2007
- Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000New England Journal of Medicine, 2007
- Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary SyndromesCirculation, 2004
- Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial q-wave and non-q-wave myocardial infarction: a multi-hospital, community-wide perspectiveJACC, 2001
- Acute Coronary Syndromes in the GUSTO-IIb TrialCirculation, 1998